Yung H. Kao

300 Grattan Street
Parkville, VIC 3050, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

Tumour SUVmean and volume relates to its radiation absorbed dose.

Tumour SUVmean and volume relates to its radiation absorbed dose.

Journal: EJNMMI reports

Published: June 02, 2026

Correlation of Tumor Absorbed Dose with Progression-Free Survival in Metastatic Castration-Resistant Prostate Cancer Treated with 177Lu-PSMA.

Correlation of Tumor Absorbed Dose with Progression-Free Survival in Metastatic Castration-Resistant Prostate Cancer Treated with 177Lu-PSMA.

Journal: Journal of nuclear medicine technology

Published: June 06, 2025

Rapid Predictive Dosimetry Is Now Freely Available.

Rapid Predictive Dosimetry Is Now Freely Available.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: June 02, 2025

Direct Correlation of Tumor Absorbed Dose with Overall Survival in Metastatic Castration-Resistant Prostate Cancer Treated with 177Lu Prostate-Specific Membrane Antigen.

Direct Correlation of Tumor Absorbed Dose with Overall Survival in Metastatic Castration-Resistant Prostate Cancer Treated with 177Lu Prostate-Specific Membrane Antigen.

Journal: Journal of nuclear medicine technology

Published: February 05, 2025

177 Lu-PSMA With Olaparib Radiosensitization Potentiates Response and Toxicity in Extensive Castration-Resistant Metastatic Prostate cancer.

177 Lu-PSMA With Olaparib Radiosensitization Potentiates Response and Toxicity in Extensive Castration-Resistant Metastatic Prostate cancer.

Journal: Clinical nuclear medicine

Published: August 02, 2024

Rapid predictive dosimetry for radioembolization.

Rapid predictive dosimetry for radioembolization.

Journal: Asia Oceania journal of nuclear medicine & biology

Published: January 02, 2024

First-Strike Rapid Predictive Dosimetry and Dose Response for 177Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer.

First-Strike Rapid Predictive Dosimetry and Dose Response for 177Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer.

Journal: Journal of nuclear medicine technology

Published: November 16, 2023

A simplified general schema for rapid single time-point marrow predictive dosimetry.

A simplified general schema for rapid single time-point marrow predictive dosimetry.

Journal: Nuclear medicine communications

Published: September 14, 2023

Rapid predictive dosimetry for Second Strike prescription based on whole body radioiodine kinetics in differentiated thyroid cancer.

Rapid predictive dosimetry for Second Strike prescription based on whole body radioiodine kinetics in differentiated thyroid cancer.

Journal: Asia Oceania journal of nuclear medicine & biology

Published: May 28, 2023

First Strike personalized predictive radioiodine prescription for inoperable metastatic differentiated thyroid cancer.

First Strike personalized predictive radioiodine prescription for inoperable metastatic differentiated thyroid cancer.

Journal: Asia Oceania journal of nuclear medicine & biology

Published: January 13, 2023

Empiric radioiodine for hyperthyroidism: Outcomes, prescribing patterns, and its place in the modern era of theranostics.

Empiric radioiodine for hyperthyroidism: Outcomes, prescribing patterns, and its place in the modern era of theranostics.

Journal: Clinical endocrinology

Published: January 24, 2022

Single-Time-Point Tumor Dosimetry Assuming Normal Distribution of Tumor Kinetics.

Single-Time-Point Tumor Dosimetry Assuming Normal Distribution of Tumor Kinetics.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: December 22, 2021

Showing 1-12 of 46

Last Updated: 09/26/2026